- Home
- SBFM vs SYTA Comparison
SBFM vs SYTA Comparison
Compare SBFM & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- SYTA
- Stock Information
- Founded
- SBFM 2006
- SYTA N/A
- Country
- SBFM United States
- SYTA Canada
- Employees
- SBFM N/A
- SYTA N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- SYTA Telecommunications Equipment
- Sector
- SBFM Health Care
- SYTA Telecommunications
- Exchange
- SBFM Nasdaq
- SYTA Nasdaq
- Market Cap
- SBFM 3.7M
- SYTA 3.3M
- IPO Year
- SBFM N/A
- SYTA 2020
- Fundamental
- Price
- SBFM $2.66
- SYTA $0.74
- Analyst Decision
- SBFM Strong Buy
- SYTA
- Analyst Count
- SBFM 1
- SYTA 0
- Target Price
- SBFM $15.00
- SYTA N/A
- AVG Volume (30 Days)
- SBFM 1.8M
- SYTA 2.0M
- Earning Date
- SBFM 11-05-2024
- SYTA 11-14-2024
- Dividend Yield
- SBFM N/A
- SYTA N/A
- EPS Growth
- SBFM N/A
- SYTA N/A
- EPS
- SBFM N/A
- SYTA N/A
- Revenue
- SBFM $32,959,491.00
- SYTA $11,988,979.00
- Revenue This Year
- SBFM $86.70
- SYTA $75.92
- Revenue Next Year
- SBFM $126.76
- SYTA $19.72
- P/E Ratio
- SBFM N/A
- SYTA N/A
- Revenue Growth
- SBFM 61.94
- SYTA 41.59
- 52 Week Low
- SBFM $2.11
- SYTA $0.64
- 52 Week High
- SBFM $608.00
- SYTA $90.90
- Technical
- Relative Strength Index (RSI)
- SBFM 47.83
- SYTA 35.57
- Support Level
- SBFM $2.51
- SYTA $0.62
- Resistance Level
- SBFM $2.82
- SYTA $0.94
- Average True Range (ATR)
- SBFM 0.29
- SYTA 0.10
- MACD
- SBFM -0.02
- SYTA 0.00
- Stochastic Oscillator
- SBFM 22.34
- SYTA 15.94
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.